Investigation of influence of process variables on mechanical strength, size and homogeneity of pharmaceutical granules produced by fluidised hot melt granulation by Mangwandi, Chirangano et al.
Investigation of influence of process variables on mechanical
strength, size and homogeneity of pharmaceutical granules
produced by fluidised hot melt granulation
Mangwandi, C., Zainal, N. A., JiangTao, L., Glocheux, Y., & Albadarin, A. B. (2015). Investigation of influence of
process variables on mechanical strength, size and homogeneity of pharmaceutical granules produced by
fluidised hot melt granulation. Powder Technology, 272, 173-180. DOI: 10.1016/j.powtec.2014.11.042
Published in:
Powder Technology
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
This is the author’s version of a work that was accepted for publication in Powder Technology. Changes resulting from the publishing
process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this
document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently
published in Powder Technology, vol 272, issue March 2015 doi: 10.1016/j.powtec.2014.11.042.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
INVESTIGATION OF INFLUENCE OF PROCESS VARIABLES ON MECHANICAL 1 
STRENGTH, SIZE AND HOMOGENEITY OF PHARMACEUTICAL GRANULES 2 
PRODUCED BY FLUIDISED HOT MELT GRANULATION 3 
 4 
Chirangano Mangwandi*1, N. A. Zainal1, Liu JiangTao1, Y. Glocheux1, Ahmad B. Albadarin1,2 5 
 6 
1School of Chemistry and Chemical Engineering, Queen's University Belfast, 7 
Belfast BT9 5AG, Northern Ireland UK 8 
2Synthesis & Solid State Pharmaceuticals Center (SSPC),  9 
Department of Chemical and Environmental Science, 10 
University of Limerick, Ireland. 11 
 12 
 13 
 14 
Corresponging Author details: 15 
Tel: +44 (0) 28 9097 4378 16 
Fax: +44 (0) 28 9097 6524 17 
E-MAIL: C.MANGWANDI@QUB.AC.UK 18 
 19 
Keywords: Active pharmaceutical ingredient; homogeneity; granule strength; granule size; 20 
Fluidised hot melt granulation (FHMG); methylene blue 21 
 22 
1 
 
 23 
 24 
INVESTIGATION OF INFLUENCE OF PROCESS VARIABLES ON MECHANICAL 25 
STRENGTH, SIZE AND HOMOGENEITY OF PHARMACEUTICAL GRANULES 26 
PRODUCED BY FLUIDISED HOT MELT GRANULATION 27 
C. Mangwandi1*, N. A. Zainal1, Liu JiangTao1, Y. Glocheux1, A.B. Albadarin1,2 28 
1School of Chemistry and Chemical Engineering, Queen's University Belfast, 29 
Belfast BT9 5AG, Northern Ireland UK 30 
2Materials Surface Science Institute, Department of Chemical and Environmental Sciences, 31 
University of Limerick, Ireland. 32 
 33 
 34 
ABSTRACT  35 
The overall aim of the project was to study the influence of process variables on the 36 
distribution of a model active pharmaceutical ingredient (API) during fluidised melt 37 
granulation of pharmaceutical granules with a view of optimising product characteristics. 38 
Granules were produced using common pharmaceutical excipients; lactose monohydrate 39 
using poly ethylene glycol (PEG1500) as a meltable binder. Methylene blue was used as a 40 
model API. Empirical models relating the process variables to the granules properties such as 41 
granule mean size, product homogeneity and granule strength were developed using the 42 
design of experiment approach. Fluidising air velocity and fluidising air temperature were 43 
shown to strongly influence the product properties. Optimisation studies showed that strong 44 
granules with homogeneous distribution of the active ingredient can be produced at high 45 
fluidising air velocity and at high fluidising air temperatures.  46 
 47 
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1 Introduction  48 
Size enlargement processes have been extensively used in the pharmaceutical industry to 49 
reduce the potential difficulties in the manufacture of solid dosage due to poor 50 
compactibilty, compressibility and flowability of many drugs [1]. There are a number of 51 
granulation techniques that have been applied such as high shear granulation, twin extrusion 52 
and fluidised bed granulation. In an effort to overcome some of the limitations of the 53 
conventional process, new granulation techniques are being investigated and developed, 54 
among these processes is melt granulation (MG) technique [1].  55 
Melt granulation is a size enlargement process in which powders are agglomerated using 56 
low-melting point materials as meltable binders. The meltable binders can be added either as 57 
molten liquid or as solid that melts during the process. During the process, heat is 58 
continuously applied to maintain molten state of the binder consequently facilitating granule 59 
formation. Once the correct size of the granules is achieved the system is cooled to allow 60 
solidification of the binder. MG can be performed in a high shear mixer or a fluidised bed 61 
unit, with the former being the most common. The process is named in accordance to the 62 
type of equipment used, high shear melt granulation (HSMG) or fluidised bed melt 63 
granulation (FBMG). There are a number of articles that have been published that look at the 64 
effect of process variables in HSMG [2-7]. Similarly several articles which can be found in 65 
literature that looks at the effect of process variable on the granule growth kinetics in 66 
FBMG. In FBMG binder is sprayed onto a bed of agitated powder. The binder droplets wet 67 
the powder particles thereby forming liquid bridges which subsequently solidify to form 68 
solid bridges upon cooling. The fluidising temperature, binder spray rate, type of binder, 69 
droplet size and binder viscosity have been shown to significantly affect the process [1, 2, 8-70 
10].  71 
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Fluidised hot melt granulation (FHMG) is an alternative to FBMG and HSMG; this is a 72 
novel process in which granules are produced by mixing low-melting point binders with 73 
other excipients and drug directly in fluid bed of hot air. Unlike FBMG and HSMG no 74 
spraying system is required. In comparison to other conventional granulation techniques 75 
fluidised hot melt granulation offers several advantages [1, 11]. For instance there is no need 76 
to use solvents hence no solvent recovery issues and associated safety and environmental 77 
considerations are eliminated. It is a good alternative to wet granulation when dealing with 78 
moisture sensitive materials. 79 
In the literature regarding the effect of process and formulation variables of granule 80 
homogeneity in high shear granulation, most of these articles identified impeller speed, 81 
amount of binder, primary particle size, chopper speed and hydrophobicity of the 82 
components as contributors to product homogeneity / heterogeneity [3, 5, 6, 12-18]. Some of 83 
the studies on FHGM have been centred on understanding the granulation mechanism [11, 84 
19] and the influence of the process and formulation variables on granule properties like 85 
size, growth kinetics and strength [1, 9, 10, 20, 21]. The subject of product homogeneity in 86 
FHGM has received limited attention.  87 
The aim of this research was to study the influence of process variables on API 88 
homogeneity of granules produced via fluidised bed melt granulation with a view of 89 
optimising the process for product homogeneity. It is not sufficient to have a granular 90 
product that is homogeneous in terms of the composition. The mechanical properties of the 91 
product are also very important as they influence the post granulation processes and 92 
handling [22]. The influence of fluidising air velocity (FAV), fluidising air temperature 93 
(FAT) and granulation time on product homogeneity were investigated.  94 
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2 Materials and Methods 95 
2.1 Materials 96 
Lactose monohydrate powder, supplied by Sigma Aldrich GmbH, was used as the main 97 
excipient. The binder was poly (ethylene glycol) with an average molecular weight of 1500 98 
(81210 Fluka analytical grade), produced and supplied by Sigma Aldrich GmbH, Germany. 99 
Methylene Blue (MB) - high purity biological strain, produced and supplied by Sigma 100 
Aldrich, was used as a model active ingredient. The lactose powder had mean size (d50) of 101 
about 50 micrometres. The size of the MB powder particles was less than 75 microns.  102 
2.2 Granulation Equipment 103 
A Sherwood Scientific (Mark II) Fluidised Bed Drier was used for granulation of lactose 104 
monohydrate, MB and PEG mixture. It consists of a 5 litre glass container with a fine mesh 105 
nylon gauze air distributor, stainless steel support gauze and a filter bag at the top of the unit. 106 
The inlet air temperature of the granulator can be controlled accurately to ±1 °C.  107 
2.3 Granule production   108 
Preliminary experiments were done to find the feasible range of process variables over 109 
which it was possible to produce decent granules in the fluidised bed unit. The results showed 110 
that granulation time in the range 10 to 20 minutes, blower speed settings between 4 and 6 111 
and bed temperature of between 50 and 60 ⁰C would be suitable for granule production. The 112 
PEG1500 flakes were mashed through a 0.5 and 1.0 mm sieves. Trial experiments on the 113 
suitable binder to solid ratio showed that a ratio of 0.1 was suitable. Each batch was 114 
composed of 200 g of lactose powder, 20 g of the PEG1500 particles and 200 mg of MB 115 
powder.  116 
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Two-level factorial design with 5 repetitions in the central point was used to investigate 117 
the influence of the process variables of the granules properties and variability in API 118 
concentrations in the granules and tablets. Design of experiment (DOE) software, Design 119 
Expert Version 8 (Stat Easy Inc., USA), was used to produce a list of experiments and to 120 
analyse the results. A three level factorial design was used to study the influence of fluidising 121 
air velocity, granulation time and bed temperature on the product characteristics. Table 1 122 
shows the process variables that were investigated.  123 
2.4 Characterisation of the granules 124 
2.4.1 Size analysis  125 
The granules were then sieved using Retsch sieves on an orbital sample shaker (Stuart 126 
Orbital Shaker, Cole-Parmer, UK) for 5 minutes at speed of 180 rpm. Previous work done by 127 
our research group with similar type of granules, showed that at this setting the amount of granule 128 
breakage was insignificant. The aperture sizes of the sieves used in the analysis were in the 129 
range 500 to 4000 µm. 130 
The mass mean diameter ( md ) of the granules was calculated according to; 131 
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In Eq. (1)  im  is mass of granules in the interval ix  to 1+ix   and  x  is average size of the size 133 
class given by ( )2
1++= ii xxx . 134 
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2.4.2 Granule Strength Analysis 135 
The strength of granules in the size range 1.4 to 1.7 mm was determined from compression 136 
of a bed of granules in a confined cylindrical die using a method previously described in [23]. 137 
The choice of this size range for all the analysis of the granules was based on the availability 138 
of the sufficient granules from this class across all batches that were produced. The punch 139 
used in the test had a diameter of 9.95 mm and the dimensions of the die were as follows; 140 
internal diameter of 10 mm; external diameter of 22 mm and height of 10 mm. Work done 141 
earlier on similar granules had shown that the granules were strain rate- independent for compression 142 
speed ranging from 0.1 to 50 mm/min. The beds of granules were compressed to a maximum 143 
compression force of 500 N using a compression test speed of 10 mm/min. The setting of 144 
10mm/min was chosen allowed compression tests to be performed within a reasonable time 145 
whilst also provide sufficient data points for the analysis. The force-displacement data 146 
obtained during the compression of bed or granules were analysed using a method described 147 
previously [13, 24, 25] to obtain the single granule strength. Equation (2) was fitted to the 148 
plot of lnP versus natural strain to obtain the granule strength parameter. 149 
( )αεαε
α
τ −−++




= eP 1lnlnln         Eq. 2 150 
In Eq. 2 α  is a pressure coefficient,  τ  the Adam’s parameter, P  is the applied pressure and 151 
ε  is the natural strain.    152 
2.4.3 Determination of API Concentration calibration  153 
Solutions of different concentrations of the pseudo API ranging from 1 to 20 ppm were 154 
produced by dissolving the MB in deionised waster. The absorbance of the resultant solutions 155 
at a wavelength of 664 nm was measured with a spectrophotometer (HACH DR2800, HACH 156 
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Inc, USA). The calibration equation for conversion of absorbance to concentration was 157 
obtained from the linear plot and the concentration was correlated to absorbance according 158 
to: 159 
0358.01666.5 664 += AcMB     Eq. 3 160 
In Eq. 3 
MBc  is the concentration of the MB solution and 664A   is the absorbance of the solution at a 161 
wavelength of 664 nm. The correlation coefficient, 2R , of the plot of 
MBc   versus 664A   was 0.9991. 162 
2.4.4 Composition Analysis of granules  163 
The distribution of the API across different size of the granules was measured by 164 
dissolving a known mass of granules in a known volume of distilled water and measuring the 165 
absorbance of the colloid at a wavelength of 664 nm using a spectrophotometer. The 166 
concentration (in ppm) of the colloid was calculated using Eq. 3.  The concentration of the 167 
MB in dry sample (mg/g) was them determined from; 168 
( ) ( ) ( )VxmmmMBi ispMBMB cxc )(exp, ××=        Eq. 4 169 
where MBm  is the mass of MB added to the batch; pm  is total mass of powder (mass of 170 
lactose and solid binder PEG); )( is xm mass  of sample granules of from size class ix  used in 171 
measurement; V  (in litres) is volume of dissolution medium.  172 
2.4.5 Composition homogeneity across single size 173 
Ten random samples of approximately 1 g of granules in the required size range (1.4 to 1.7 174 
mm) were withdrawn from each batch. Colloids were prepared from each of the samples by 175 
adding the granules to 25 ml of de-ionised water. The concentration of the methylene blue 176 
solution was obtained by measuring the absorbance of the solution at a single wavelength of 177 
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664 nm and calculating the concentration from the previously determined calibration 178 
equation. For each batch the coefficient of variation was calculated using [13, 23];  179 
cˆ
σκ =            Eq. 5 180 
where cˆ is the mean of the samples and σ  is the standard deviation of methylene blue 181 
concentration in the samples; 182 
 The homogeneity coefficient, η, was then defined as; 183 
κη −= 1            Eq. 6 184 
where κ is as defined in Eq. 5 and 10 ≤≤ η . Homogeneity coefficient of 1 corresponds to a 185 
completely homogeneous distribution of the pseudo active ingredient while a low value of η 186 
indicates poor distribution.   187 
3 Results & Discussion 188 
Table 2 summarises the results of mean granule size, granules strength and coefficient of 189 
variation of the API in the granules in the size range 1.4 to 1.7 mm.   190 
3.1 Preliminary results 191 
The effect of powder binder particle size on the size distribution of the granules was 192 
investigated by granulating lactose powder with the PEG binder of different sizes; flakes as 193 
received, flakes grated through the 0.5 mm sieve, and flakes grated through 1.0 mm sieve. 194 
The other granulation conditions such as granulation time and fluidising air velocity were 195 
kept constant at 15 minutes and 2.25 m/s respectively. The cumulative size distribution 196 
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curves and the plot of granule median size for the different flake particle sizes are shown in 197 
Fig. 1. It is clear from these results that the final granule size is strongly influenced by the 198 
size of the binder particle. Increasing the size of the particle increases the granule median 199 
size. The PEG particles melt as the temperature of the bed increases creating nuclei for 200 
granule growth. The size of nuclei formed depends on the size of PEG flake particles, larger 201 
flake particle result in formation of large nuclei which is then translated to the size of the 202 
granules formed.  203 
3.2 MB distribution 204 
The subject of inhomogeneity of drug and binder across different size has received a lot of 205 
attention in literature [13, 16, 26-31].  Several possible causes of drug inhomogeneity have 206 
been discussed namely difference in the particle sizes of constituents, different in solubility 207 
[32] and migration of the drug particles [33].  It has been shown by numerous researchers that 208 
primary particle size plays an important role in determining the product homogeneity. If the 209 
particle size distributions of the starting materials are similar then a homogeneous product is 210 
expected. It was observed that granulation involving drugs with finer particle sizes compared 211 
to filler material resulted in a product were the smaller granules would be super potent [34]. 212 
However the opposite is observed if the drug particles are coarser than the filler the larger 213 
granules would be super-potent [26, 35]. A typical distribution of the MB across different 214 
sizes of granules is depicted in Fig. 2. This shows that distribution is bimodal with the peaks 215 
around 0.3 mm and 1.5 mm. It also shows that granules larger than 2 mm have lower MB 216 
content. The average concentration of MB in the granules across all sizes is shown in Fig. 3. 217 
It is evident from the figure that some of the granules are richer in the MB compared to the 218 
other granules, for instance for batch 1 granules in the size ranges 0.5 to 0.6 mm and 1.7 to 219 
2.0 mm had concentration above the theoretical expected value of ~0.91 mg/g.  220 
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3.3 Effect of process variables on granule size and size distributions 221 
The effect of process variable on the size distribution of the granules was investigated 222 
from granulation of lactose monohydrate powder, PEG 1500 (particle size < 1 mm) and 223 
methylene blue. The granules mean sizes for the different batches obtained using Eq.1 are 224 
presented in Table 2. The granule mean sizes were ranging from about 0.85 to 1.88 mm. The 225 
minimum granule mass mean diameter was obtained in Batch 6 when the fluidised bed 226 
temperature, fluidising air velocity and granulation time were 50 °C, 2.45 m/s and 20 minutes 227 
respectively. The maximum was obtained in Batch 5 when the fluidised bed temperature, 228 
fluidising air velocity and granulation time were 60 °C, 2.03 m/s and 20 minutes respectively. 229 
The typical size distribution curves for these two batches of experiments are shown in Fig. 230 
4. It is quite evident that Batch 6 has lower fraction of large granules, and a large fraction of 231 
granules less with an equivalent diameter less than 1.7 mm.  232 
A summary of the statistical analysis of the effect of the granulation process variables is 233 
given in the ANOVA table presented in Table 3.  234 
The granule mass mean size can be written in terms of the coded process variables A, B, 235 
and C representing the temperature, fluidisation air velocity and granulation time 236 
respectively. This is given as; 237 
CBCACBAdmean 15.022.01084.321.021.006.1
3 −+×+−++= −        Eq. 7 238 
According to Eq.7 all three process variable significantly affect the mean size of granules 239 
produced by fluidised bed hot melt granulation.  Judging from the coefficient of A and B in 240 
Eq. 7, the relative contribution of the fluidising air velocity and fluidised bed temperature to 241 
the granule mean size is almost of similar scale. Granulation time has slightly less effect on 242 
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the mean granule size.  However the interaction between granulation time and fluidised bed 243 
temperature is also very strong as can be noted from the high coefficient values of the A*C 244 
term.  245 
The granule mass mean size can also be written in terms of the actual process variables as;  246 
UtttUdmean 173.01091.8102.0575.10925.0626.2
3 +×+−+−+= − θθ   Eq. 8 247 
In Eq. 8 U  is the fluidising air velocity, θ  is the fluidised bed temperature and t  is the 248 
granulation time.  249 
To visualise the effect of the process variable on the granule mass mean size Eq. 8 was 250 
used to calculate the granule mass mean size for various combinations of fluidising bed 251 
temperature, fluidised air velocity and granulation times and presented in form of mesh plots 252 
(Fig. 5). Fig. 5 shows the effect of varying both the fluidising air velocity and fluidised air 253 
temperature on the granule mass mean size whilst maintaining the granulation time constant 254 
at 20 minutes. Increasing the temperature from 50 °C to 60 °C has an effect of increasing the 255 
granule mass mean size. This increase in granule size may be attributed to increase in the 256 
number of binder droplets formed due to melting of the binder at higher temperatures. The 257 
increase in the number of droplets increases the chances of bond formation between the 258 
powder primary particles. The interesting point to note is that the relative change in the size 259 
of granulation with respect to change in temperature is lower at higher fluidising air 260 
velocities. At higher fluidising air velocities increased loss of binder by evaporation which 261 
effects the bond formation; less binder becomes available for bond formation. This trend is 262 
similar to earlier reports in literature of fluidised bed wet granulation [20, 36, 37]. According 263 
to previous work, higher fluidising air velocity favours loss of binder through evaporation 264 
[37], however in the work reported here the amount of binder lost in this way would be 265 
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insignificant since the binder hardly evaporates at the fluidised temperature investigated here.   266 
Their results show that slower granule growth rate was obtained at higher fluidising air 267 
velocity compared to what was obtained at lower velocities. It was postulated that decreasing 268 
the fluidising air velocity would increase the probability of contact between wetted particles. 269 
On the contrary in another separate study [38],  increasing fluidised air velocity was found to 270 
increase the  mean size of the granules.  In this study the moisture content level was 271 
maintained at the same value. The increase in the mean granule size could be attributed 272 
higher bed expansion observed at higher fluidising air velocity. This might have resulted in 273 
an increase in the probability in granule formation as the bed expansion reduced the 274 
separation between the spray zone and bed. 275 
Fig. 5 also shows the effect of changing the granulation time on the granule mass mean 276 
size. This figure illustrates that at shorter granulation times the effect of fluidising air velocity 277 
and fluid bed temperature on the granulation size is less pronounced; the granule mass mean 278 
size is roughly 1.0 mm. The effect of these two variables become significant as the 279 
granulation time is increased; the rate of increase of size with respect to temperature increases 280 
whilst the rate of change of the size with respect to air velocity also becomes more evident.  281 
3.4 Effect of process variables on granule homogeneity 282 
The statistical analysis (ANOVA) of the results on the effect of the process variables on 283 
the drug homogeneity of the samples taken from granules in the size range 1.4 to 1.7 mm is 284 
presented in Table 4. According to results present in Table 4 the model adequately describes 285 
the data (p-value = 0.0005). The process variables namely; fluidising air velocity, fluidised 286 
bed temperature and granulation time, are important in determining the homogeneity of the 287 
drug in the granules studied. The interaction between the fluidised bed temperature and 288 
granulation time is also strong.  289 
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An empirical model for the uniformity coefficient of the API in the granules was 290 
determined from statistical analysis of the data. The effect of the uniformity coefficient is 291 
related to the coded process variables according to; 292 
[ ]31013.0015.0018.0012.094.0 CACBA −−+−+=η      Eq. 9 293 
The terms A, B and C are as defined before. When expressed in terms of the natural 294 
process variables the uniformity coefficient equation reduces to; 295 
[ ]3143 1030.50261.00879.01050.5488.0 ttU θθη −− ×−++×+=     Eq. 10 296 
All the symbols are as defined previously.  297 
The surface plot of the granule homogeneity for three different granulation times is 298 
shown in in Fig. 6. The surface plot shows that increasing the speed of the fluidising air 299 
velocity results in improvement in the homogeneity of the granules; the homogeneity 300 
coefficient increase from 0.97 to around 0.99 when the granulation temperature is 50 °C. It 301 
can also be noted that at this temperature the granulation time has little influence on the 302 
homogeneity coefficient. However when the fluidising air temperature is set at 60°C the 303 
influence of the temperature on the homogeneity factor becomes more significant; shorter 304 
granulation time favours better homogeneity.   305 
Increasing the fluidising air velocity can result in more breakage of the agglomerates 306 
which manifests as reduction in the growth rate [9, 10] or a reduction in average granule size 307 
[38-40]. It has been reported in literature that breakage of particles during the granulation 308 
process promotes material exchange between the granules which improves product 309 
homogeneity [15, 16]. It would then be logical to expect an increase in the homogeneity of 310 
the product as the fluidising air velocity is increased. This is illustrated in Fig. 6 where 311 
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increasing the fluidising air velocity is shown to result in an increase in the homogeneity 312 
coefficient.  According to Fig. 6 the influence of fluidising air on the homogeneity is more 313 
pronounce at high temperature than at lower temperatures. Within the design space studied in 314 
this work reasonably high level of homogeneity were achieved despite the fact that pseudo 315 
active ingredient was added as a solid and very low proportion.  316 
3.5 Effect of process variables on granule strength 317 
Another important aspect to look at when analysing the homogeneity of the granules is 318 
the strength of the granules. The influence of the processing conditions on the strength of 319 
then granules was also investigated in this work and an empirical equation relating the 320 
granule strength determined from confined compression test of bed of granules as described 321 
in Section 2.5. Within the range of the process variables studied here, the FAV and FAT were 322 
found to strongly affect the strength of the granules. The statistical analysis of the results is 323 
summaries in ANOVA table presented in Table 5 show that chosen model is suitable for  324 
describing the data obtained in the experiments (p-value = 0.0137). The FAV, with an 325 
associated p-value of 0.0055, is the most important variable affecting the strength of the 326 
granules. The granulation time was found not to be an important factor on the strength of the 327 
granule. There is also strong interaction between FAV and FAT (p- value = 0.0346).  328 
The granule strength,τ , is related to the process conditions according the empirical 329 
equation; 330 
UU θθτ 4398.08.20972.009.48 +−−+=        Eq. 11 331 
In Eq.11 the symbols θ  and U are as defined previously. The empirical equation 332 
predicts that the granule strength decreases with increasing values of fluidising air velocity 333 
and fluidising air temperature. The surface plot shown in Fig. 7 shows the effect of fluidising 334 
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air velocity and fluidising air temperature on granule strength. The figure shows that the 335 
highest granule strength was obtained at high fluidising air temperature and high fluidising 336 
air velocity. The interaction effects between the fluidising air velocity and air temperature is 337 
quite evident in Fig. 7. It is clear that the influence of fluidising air temperature on granule 338 
strength depends on fluidising air velocity; at low fluidising air velocity increasing the 339 
temperature of the bed does not result in an increasing in the strength of the granules as seen 340 
at high fluidising air velocity.  341 
3.6  Optimisation 342 
One of the important uses of the experimental design is process optimisation. In this case 343 
the empirical model developed from design of experiments, was used to predict the process 344 
conditions that can used to produce granules with desired attributes. Here the DOE was used 345 
to predict optimum process and formulation variables that are required to produce granules 346 
with suitable strength and with the highest level of homogeneity. The granule should be 347 
strong enough to survive stringent forces that they experience during transportation and 348 
handling. The criteria used to determine the process conditions is summarised in Table 6. 349 
Different weighting was ascribed to the different input variables and the response variables. It 350 
is shown in Table 6 that all the process variables were assigned equal importance with a 351 
default weighting of 3. It is important that the granules produced would have sufficient 352 
strength for handling during post granulation processes and is also equally important they have 353 
homogeneous distribution of the API; hence these two granule attributes were given high weighting 354 
during the optimisation.  355 
The desirability objective function is given by [41]; 356 
( )
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∑
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
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In the above equation rj is degree of importance and d1 is the desirability factor of 358 
variable. Importance (ri) varies from the least important a value of 1, to the most important a 359 
value of 5. Detailed description of the models and equations can be found elsewhere [41, 42].  360 
Desirability plot for the design space is shown in Fig. 8. The plot shows that the highest 361 
desirability of about 0.94 is achieved at the highest temperature and fluidising air velocity. A 362 
high value (close to 1) of the desirability functions indicates that constraints for the 363 
optimisation of response functions are being closely satisfied. As can be seen in Fig. 8 the 364 
values of desirability approach a value of 1 as the fluidising air velocity is increased and 365 
highest values are achieved when both fluidising air velocity and bed temperature are high. 366 
This result means that constraints set up for the optimisation are closely matched when 367 
fluidising air flow rate and bed temperature are both high. The summary of conditions for 368 
formation of strongest granules with highest homogeneity is given in Table 7.  This table 369 
shows that granules with optimum attributes can be obtained with a granulation time of 11.37 370 
minutes at fluidising bed temperature of 60 °C with fluidising air velocity of 2.45 m/s. The 371 
expected mean size of the granules is about 1 mm and strength of granules will be around 372 
3.31 MPa. The homogeneity coefficient of the granules is 0.9895 which is close to unit.  373 
4 Conclusion 374 
It can be concluded from the work presented here that within the range of operation 375 
variables investigated in this work high levels of homogeneity of the API in the granules 376 
could be achieved through fluidised bed hot melt granulation. Whereas granulation time had 377 
little influence on the granule homogeneity, fluidising air velocity and fluidised air 378 
temperature had a strong influence. It is postulated that increasing the fluidising air velocity 379 
increases breakage of granules due to increased frequency of granule to granule collision and 380 
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collision with the other component of the granulator. This increase in breakage results in the 381 
formation of a more homogeneous product. Fluidising air temperature is thought to influence 382 
the availability of binder for agglomeration process. Rate of formation of nuclei should 383 
increase as the temperature of the bed is increased to levels above the melting point of the 384 
binder. The viscosity of the binder droplets formed when the PEG particles melt should 385 
decreases with increasing fluidised bed temperature. The strength of the nuclei formed is also 386 
a function of binder viscosity; increasing the viscosity increases the strength and opposite is 387 
observed as the viscosity is decreased. It is also known that breakage is a function of strength 388 
of the nuclei therefore it would then be logical to expect the rate of breakage of the nuclei to 389 
be high at higher temperatures. Hence high fluidised bed temperature would be expected to 390 
enhance product homogeneity as observed. 391 
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Table 1: Summary of process variables and their range of values. 534 
Variable Level 
Low (-1) Medium (0) High (+1) 
Blower Speed Setting 
Fluidising Air Velocity (m/s) 
4 
2.04 
5 
2.25 
6 
2.45 
Fluidising Air Temperature (°C) 50 55 60 
Granulation Time (min) 10 15 20 
 535 
 536 
 537 
 538 
 539 
 540 
 541 
542 
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Table 2: Effect of process conditions: temperature, air velocity and granulation on size, strength and 543 
homogeneity coefficient. 544 
No. θ (°C) U (ms-1) t (min) dmean (mm) τ (MPa) η  (-) 
1 50 2.03 20 0.99 1.73 0.9766 
2 55 2.25 15 1.09 1.15 0.9802 
3 60 2.03 10 1.06 1.28 0.9791 
4 55 2.25 15 1.12 1.53 0.9829 
5 60 2.03 20 1.88 0.68 0.9551 
6 50 2.45 20 0.85 2.62 0.9881 
7 50 2.03 10 1.11 1.76 0.9786 
8 60 2.45 20 1.07 2.85 0.9735 
9 55 2.25 15 1.11 2.78 0.9841 
10 60 2.45 10 1.10 3.67 0.9894 
11 55 2.25 15 1.03 3.10 0.9852 
12 55 2.25 15 1.10 2.36 0.9835 
13 50 2.45 10 1.033 1.83 0.9887 
 545 
  546 
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 547 
Table 3: ANOVA analysis for the selected factorial model for granules median size. 548 
Source   SSa          DFb    MSc          F-value         p-value 
Model  0.61  5 0.120  71.48  <0.0001 
  A-FAT   0.240  1 0.240  99.36  <0.0001 
  B-FAV               0.250  1 0.250  105.14  <0.0001 
  C-t  8.32×10-5 1 8.32×10-5 0.047  0.8351 
  AC  0.28  1 0.28  159.18  <0.0001 
  BC  0.18  1 0.18  101.10  <0.0001 
Residual  0.011                6 1.758×10-3  
Lack of fit            5.506×10-3                2            2.522×10-3                 1.83                 0.2724 
Pure Error 5.506×10-3 4 1.377×10-3 
Cor Total 0.62  11 
 Std. Dev.  0.042                          R2 = 0.9835 
 Mean 1.13                         
   PRESS1                                       N/A                
N.B.   a SS - Sum of Squares   bDF. - Degrees of freedom 549 
  c MS –Mean Squares    dPRESS – Predicted Residuals Sum of Squares550 
  551 
 552 
 553 
  554 
 555 
 556 
 557 
  558 
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 559 
Table 4: ANOVA table for selected factorial model for uniformity coefficient.  560 
Source SSa               DFb     MSc              F-value             p-value           
 Model 7.02×10-3 4 1.765×10-3 18.1 0.0005  
   A-FAT 1.20×10-3 1 1.20×10-3 12.4 0.0078 
   B-FAV 2.30×10-3 1 2.60×10-3 26.7 0.0009 
   C-t  1.82×10-3 1 1.82×10-3 18.7 0.0025 
   AC  1.41×10-3 1 1.42×10-3 14.5 0.0052  
 Residual 7.76×10-4 8 9.72×10-5 
 Lack of Fit 6.61×10-4 4 1.65×10-4 5.5 0.0516  
 Pure Error 1.15×10-4 4 2.88×10-5 
 Cor Total 7.80×10-3 12 
 Std. Dev.  9.848×10-3                          R2 = 0.9005 
 Mean 0.94  
 C.V. % 1.04  
 PRESSd 2.469×10-3                 
N.B.   a SS - Sum of Squares   bDF. - Degrees of freedom 561 
         c MS –Mean Squares          dPRESS – Predicted Residuals Sum of Squares 562 
 563 
 564 
 565 
  566 
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Table 5: ANOVA for selected factorial model for granule strength.  567 
Source SSa               DFb     MSc  F-value p-value           
 Mode  5.47 3 1.82  7.49 0.0137  568 
   A-FAT 0.036 1 0.036 0.15 0.7101 569 
   B-FAV 3.81 1 3.81  15.67 0.0055 570 
   AB  1.62 1 1.62  6.66 0.0364 571 
 Residual 1.70 7 0.24 572 
 Lack of Fit 0.89 5 0.18  0.44 0.8008  573 
 Pure Error 0.81 2 0.40 574 
 Cor Total 7.17 10 575 
 Std. Dev.   9.848×10-3                         R2 = 0.8970 576 
 Mean  0.94                     577 
 C.V. %  1.04                   578 
  PRESSd  2.469×10-3                   579 
N.B.   a SS - Sum of Squares  bDF - Degrees of freedom 580 
          c MS –Mean Squares         dPRESS – Predicted Residuals Sum of Squares 581 
 582 
  583 
 584 
 585 
 586 
 587 
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Table 6: Summary for optimisation criteria 589 
Name Goal Limit Limit Importance 
Process variables     
Granulation Time (min)  is in range  10 20 3 
Fluidizing Air Velocity (m/s)  is in range  2.03 2.45 3 
Fluidized Bed Temperature (⁰C)  is in range  50 60 3 
Granule attributes     
Homogeneity coefficient (-) maximize  0.9735 0.9999 4 
Granule strength (MPa)  is in range  0.68 3.67 4 
Granule mean size (mm)  is in range  1.00 1.5 3 
 590 
 591 
  592 
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 593 
Table 7: Summary of process conditions giving the optimum granule characteristics. 594 
 Value Units 
Process conditions   
Granulation Time 11.31 Min 
Fluidising Air Velocity 2.45 m/s 
Fluidised Bed Temperature 60 ⁰C 
Granule Attributes   
Homogeneity Coefficient 0.9898 - 
Granule Strength 3.31 MPa 
Granule mean size 1.004 mm 
 595 
 596 
  597 
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 599 
 600 
Fig. 1: Effect of binder particle size on granule mean size. 601 
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 604 
 Fig. 2: Typical MB content distribution across different granule sizes. Results from Batch 10; 605 
Experimental conditions; fluidising air velocity: 2.45 m/s; fluidising air temperature; 60 °C and 606 
Granulation time 10 minutes.  607 
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 608 
Fig. 3: Variation of the MB concentration in granules. 609 
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 614 
 615 
Fig. 4: Comparison of granule size distributions of two different batches 616 
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 619 
 620 
Fig. 5: Surface plot showing effect of fluidising air velocity and fluidised bed temperature on the granule 621 
mass mean size for different granulation times. 622 
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 625 
Fig. 6: Effect of fluidising velocity and bed temperature on the granule homogeneity for three different 626 
processing times. 627 
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 629 
Fig. 7: effect of process variables on the granule strength. Granules used in the test were in the size range 630 
1.4 to 1.7 mm.  631 
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 634 
Fig. 8: Desirability plot. 635 
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